New research brief: How can self-insured employers prepare for the portfolio impact of high-cost gene therapies coming to market?
As new therapies come online, self-insured employers may need more than stop-loss insurance to sustain them.
A practical approach for defining outcomes and thresholds for predictive healthcare algorithm development using real-world data
As the healthcare system evolves towards value-based care, predictive algorithms can play a critical role, but their findings must be perceived as meaningful, substantial, and actionable by those outside the data science community.
Free online resource
Paying for Cures Toolkit
Start planning your financial strategies for cell and gene therapies now
Financing and Reimbursement of Cures in the US
Medical research is making significant advances toward treatments that cure major diseases, but these treatments will often entail very high up-front costs. The FoCUS Project seeks to collaboratively address the need for new, innovative financing and reimbursement models for durable therapies in the US that ensure (1) patient access for needed treatments; (2) affordability for public and private payers; and (3) the sustainability of innovation by manufacturers. This multi-stakeholder effort unites developers, providers, regulators, patient advocacy groups, payers from all segments of the US healthcare system, and academics working in healthcare policy, financing, and reimbursement.
Learning Ecosystems Accelerator for Patient–Centered, Sustainable Innovation
LEAPS seeks to modernize how we plan, produce, and use real world evidence (RWE). We believe that a Learning Ecosystem using platform-based approaches could help to reduce knowledge uncertainties, manage behavioral and economic risk, align incentives, and reduce waste and inefficiency in the healthcare system. The use of RWE could greatly reduce knowledge uncertainties to delivering the right treatments to the right patients at the right time. By eliciting and aligning incentives for all health care stakeholders in the production of RWE, (such as new payment models not typically used in healthcare, and new ways of tracking patients and outcomes over time to implement these) and through the continuous iterative learning from the use of that evidence, we can also improve the sustainability for the system.
NEWDIGS is an international “think and do tank” dedicated to delivering more value faster to patients, in ways that work for all stakeholders. NEWDIGS designs, evaluates, and initiates advancements that are too complex and cross-cutting to be addressed by a single organization or market sector. Our members include global leaders from patient advocacy, payer organizations, bio-pharmaceutical companies, regulatory agencies, clinical care, academic research, and investment firms. Learn more about us
Research Briefs
Innovating methods for planning, producing, and using real-world evidence
July 20, 2023How can self-insured employers prepare for the portfolio impact of highcost gene therapies coming to market?
April 28, 2022Precision for Whom? Partnering with patients to ensure that Precision Medicine targets what matters
September 30, 2021Payer perspectives on outcomes tracking for value-based payment arrangements (VBPs)
March 25, 2021Recent News
ISPOR 2023 Workshop Recap: “From Concept to Practice: How to Tactically Design a Feasible Outcomes-Based Contract in Oncology”
May 24, 2023Symposium recap: Uncertainty Management in Drug Evaluations: From Evidence to Reimbursement & Clinical Use
May 23, 2023NEWDIGS Consortium Awarded Danaher Foundation Community Impact Grant
March 28, 2023Meet Marcelien Callenbach, FoCUS visiting research fellow
February 20, 2023Subscribe to NEWDIGS News
Be the first to get new research and notification of special events and programs! Subscribe to the NEWDIGS mailing list.
10 March 2019 at MIT
Paying for Cures Workshop
Learn more and register now
Financing and Reimbursement of Cures in the US
The FoCUS Project targets the need for new innovative financing and reimbursement models for curative medicines in the US that ensure (1) patient access for needed treatments; (2) affordability for public and private payers; and (3) the sustainability of innovation by manufacturers.
Financing and Reimbursement of Cures in the US
The FoCUS Project targets the need for new innovative financing and reimbursement models for curative medicines in the US that ensure (1) patient access for needed treatments; (2) affordability for public and private payers; and (3) the sustainability of innovation by manufacturers.